Literature DB >> 7522551

Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes.

D Rognan1, L Scapozza, G Folkers, A Daser.   

Abstract

The class I major histocompatibility complex-encoded HLA-B*2705 protein was simulated in complex with six different peptides exhibiting unexpected structure-activity relationships. Various structural and dynamical properties of the solvated protein-peptide complexes (atomic fluctuations, solvent-accessible surface areas, hydrogen bonding pattern) were found to be in qualitative agreement with the available binding data. Peptides that have been experimentally shown to bind to the protein remained tightly anchored to the MHC molecule, whereas nonbinders were significantly more weakly complexes to the protein and progressively dissociate from it at their N- and C-terminal ends. The molecular dynamics simulations emphasize the unexpectedly important role of secondary anchors (positions 1 and 3) in influencing the MHC-bound conformation of antigenic nonapeptides. Furthermore, it confirms that dominant anchor residues cannot solely account for peptide binding to a class I MHC molecule. The molecular dynamics method could be used as a complementary tool to T cell epitope predictions from the primary sequences of proteins of immunological interest. It is better suited to MHC proteins for which a crystal structure already exists. Furthermore, it may facilitate the engineering of T cell epitopes as well as the rational design of new MHC inhibitors designed to fit optimally the peptide binding cleft.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522551     DOI: 10.1021/bi00204a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two alpha beta T cell receptors.

Authors:  D Rognan; A Stryhn; L Fugger; S Lyngbaek; J Engberg; P S Andersen; S Buus
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  Barrel structures in proteins: automatic identification and classification including a sequence analysis of TIM barrels.

Authors:  N Nagano; E G Hutchinson; J M Thornton
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

3.  Functional concerted motions in the bovine serum retinol-binding protein.

Authors:  P L Chau; D M van Aalten; R P Bywater; J B Findlay
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

4.  Recovery of known T-cell epitopes by computational scanning of a viral genome.

Authors:  Antoine Logean; Didier Rognan
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

5.  3D hydrogen bond thermodynamics (HYBOT) potentials in molecular modelling.

Authors:  Oleg A Raevsky; Vladlen S Skvortsov
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

6.  Analysis methods for identifying coordinated movements during ligand unbinding.

Authors:  P L Chau; P W A Howe
Journal:  J Comput Aided Mol Des       Date:  2002-10       Impact factor: 3.686

7.  Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.

Authors:  Martin Zacharias; Sebastian Springer
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

8.  Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.

Authors:  A J Thompson; P-L Chau; S L Chan; S C R Lummis
Journal:  Biophys J       Date:  2005-12-30       Impact factor: 4.033

9.  Comparative molecular dynamics analysis of tapasin-dependent and -independent MHC class I alleles.

Authors:  Florian Sieker; Sebastian Springer; Martin Zacharias
Journal:  Protein Sci       Date:  2007-02       Impact factor: 6.725

10.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.